BACE1 and Alzheimer disease: Of note, some miRNAs, that coulddirectly inhibit BACE1, have been proposed as candidate therapeutic targets in AD.For instance, the decreased miR-340 in AD has been found to regulate theaccumulation of Aβ and neuronal survival by targeting BACE1 (Tan et al., 2020).